The Menopause Transition: Estrogen Variability, Stress Reactivity and Mood

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Perimenopausal Disorder, Stress, Emotional

In brief

Women in the menopause transition ('perimenopause') are exposed to extreme hormone variability, tend to experience a unique set of severe stressors (e.g., divorce, death of loved ones), and are also at substantially elevated risk to suffer from mood and anxiety disorders. The purpose of this research is to understand the mechanisms by which variability in estradiol (E2) is associated with the symptoms of anxiety and anhedonia (loss of interest and pleasure - a common symptom of depression). By stabilizing E2 variability with a hormonal manipulation, this research will determine the degree to which the E2 variability (or E2 levels) plays a causal role in perimenopausal anxiety and anhedonia symptoms and whether it does so by affecting biological responses to stress.

Key facts

Study ID
NCT03003949
Run by
University of North Carolina, Chapel Hill
People needed
82
Starts
2017-01-24
Expected to finish
2020-05-10
Last updated by the study team
2021-03-26

Who can join

Age: 45 and older, up to 60. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.